Could a personal coach at home boost energy for cancer patients?

NCT ID NCT03169075

Ongoing Symptom relief Sponsor: UNICANCER Source: ClinicalTrials.gov ↗

First seen Aug 03, 2026 · Last updated Aug 04, 2026 · Updated 1 time

Summary

This study tests whether a supervised, home-based exercise program can help people with metastatic cancer who are starting oral targeted therapy. Participants are randomly assigned to either a weekly 60-minute session with a trained coach or to a booklet with exercise recommendations. The goal is to see if the program improves fatigue, quality of life, and overall well-being.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Supervised home-based physical exercise program
What this could lead to: If effective, this program could offer a practical way to reduce fatigue and improve well-being for people with metastatic cancer on oral targeted therapy.
What could go wrong: The trial is early and the benefits of exercise in this setting are not yet proven. Some patients may find the program difficult to maintain, and results may not apply to all cancer types.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HOME BASED STANDARDISED ADAPTED PHYSICAL ACTIVITY PROGRAMME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer Fatigue kidney cancer liver sarcoma lung cancer metastatic malignant neoplasm in the colon metastatic melanoma metastatic neoplasm sarcoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HOME BASED STANDARDISED ADAPTED PHYSICAL ACTIVITY PROGRAMME PATIENTS TAKING ORAL TARGETED THERAPY FOR METASTATIC CANCER

Contacts and locations

Locations

CH Annecy Genevois - site d'Annecy

Annecy, 74474, France
CH Nimes - Institut de Cancérologie du Gard

Nîmes, 30000, France
CH de Cholet

Cholet, 49300, France
CHD Vendée

La Roche-sur-Yon, 85925, France
CHRU de Besançon

Besançon, 25000, France
CHU La Timone

Marseille, 13000, France
Centre Eugène Marquis

Rennes, 35042, France
Centre François Baclesse

Caen, 14076, France
GHMG - Institut Daniel Hollard

Grenoble, MD Phd, France
HIA Begin

Saint-Mandé, 94160, France
Hospices Civils de Lyon - Hôpital Louis Pradel

Lyon, 69000, France
ICO Paul Papin

Angers, 49000, France
ICO RenéGauducheau

Nantes, 44000, France
INSTITUT CURIE - Site René Huguenin St Cloud

Saint-Cloud, 92000, France
Institut Curie Paris

Paris, 75005, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.